Totals
- Total revenue
- $46,104,184
- Total expenses
- $36,965,541
- Contributions and grants received
- $46,500,752
- Grants paid
- $30,712,417
- Program service revenue
- $0
- Investment income
- $1,027,630
- Other revenue
- -$1,424,198
- Total assets, end of year
- $32,483,185
- Total liabilities, end of year
- $4,039,140
- Net assets or fund balances, end of year
- $28,444,045
- Program services expenses (Part IX)
- $32,972,409
- Management and general expenses
- $2,877,798
- Fundraising expenses
- $1,115,334
- Program service expenses (Part III)
- $32,972,409
Program services were 89.2% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1c · Fundraising events
$26,875,095
-
1f · All other contributions, gifts and grants
$19,625,657
-
3 · Investment income
total $1,027,630 · excluded $1,027,630
-
8a · Fundraising events: gross income
$911,369
-
8a · Fundraising events: contributions included on line 1c
$26,875,095
-
8b · Fundraising events: direct expenses
$2,459,842
-
8c · Net income from fundraising events
total -$1,548,473 · excluded -$1,548,473
-
10a · Gross sales of inventory
$215,688
-
10b · Cost of goods sold
$103,508
-
10c · Net income from sales of inventory
total $112,180 · excluded $112,180
-
11a · Other revenue: OTHER INCOME
total $12,095 · related or exempt $12,095
-
11e · Other revenue, total
$12,095
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $30,712,417 · program services $30,712,417
-
5 · Compensation of officers, directors and key employees
total $1,654,392 · program services $793,425 · management and general $542,020 · fundraising $318,947
-
7 · Other salaries and wages
total $1,020,185 · program services $489,267 · management and general $334,238 · fundraising $196,680
-
8 · Pension plan contributions
total $32,365 · program services $15,522 · management and general $10,603 · fundraising $6,240
-
9 · Other employee benefits
total $142,594 · program services $68,386 · management and general $46,717 · fundraising $27,491
-
10 · Payroll taxes
total $152,216 · program services $73,001 · management and general $49,870 · fundraising $29,345
-
11b · Fees: legal
total $19,741 · program services $8,170 · management and general $8,287 · fundraising $3,284
-
11c · Fees: accounting
total $76,583 · program services $31,693 · management and general $32,150 · fundraising $12,740
-
11g · Fees: other
total $547,076 · program services $226,398 · management and general $229,668 · fundraising $91,010
-
12 · Advertising and promotion
total $649,830 · program services $212,451 · management and general $145,134 · fundraising $292,245
-
13 · Office expenses
total $67,762 · management and general $67,762
-
14 · Information technology
total $323,975 · program services $155,374 · management and general $106,142 · fundraising $62,459
-
16 · Occupancy
total $150,994 · program services $72,415 · management and general $49,469 · fundraising $29,110
-
17 · Travel
total $105,687 · program services $50,686 · management and general $34,626 · fundraising $20,375
-
22 · Depreciation, depletion and amortization
total $653,456 · management and general $653,456
-
24a · Other expenses: BANK AND BUSINESS FEES
total $428,271 · program services $9,306 · management and general $415,224 · fundraising $3,741
-
24b · Other expenses: PRINTING AND PUBLICATIO
total $112,385 · program services $53,898 · management and general $36,820 · fundraising $21,667
-
24c · Other expenses: OTHER STAFF EXPENSES
total $99,841 · management and general $99,841
-
24d · Other expenses: BAD DEBT EXPENSE
total $15,771 · management and general $15,771
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $22,357,065 · end of year $9,073,767
-
3 · Pledges and grants receivable
beginning of year $8,464,719 · end of year $18,822,638
-
4 · Accounts receivable
beginning of year $2,693 · end of year $6,315
-
8 · Inventories for sale or use
beginning of year $35,690 · end of year $99,387
-
10a · Land, buildings and equipment: cost or other basis
$4,995,054
-
10b · Land, buildings and equipment: accumulated depreciation
$3,819,917
-
10c · Land, buildings and equipment, net
beginning of year $285,219 · end of year $1,175,137
-
11 · Investments: publicly traded securities
beginning of year $2,679 · end of year $8,575
-
13 · Investments: program-related
beginning of year $1,426,681 · end of year $1,549,867
-
14 · Intangible assets
beginning of year $912,853
-
15 · Other assets
beginning of year $13,357 · end of year $1,747,499
-
17 · Accounts payable and accrued expenses
beginning of year $408,329 · end of year $246,515
-
18 · Grants payable
beginning of year $12,166,190 · end of year $1,256,626
-
19 · Deferred revenue
beginning of year $771,875 · end of year $592,710
-
25 · Other liabilities
beginning of year $37,436 · end of year $1,943,289
-
27 · Net assets without donor restrictions
beginning of year $10,709,183 · end of year $6,470,363
-
28 · Net assets with donor restrictions
beginning of year $9,407,943 · end of year $21,973,682
Mission and programs · 2024
Mission
AT PELOTONIA WE'RE DRIVEN BY OUR MISSION: TO ENGAGE, INSPIRE, AND CHALLENGE A COMMUNITY COMMITTED TO CHANGE THE WORLD BY ACCELERATING INNOVATIVE CANCER RESEARCH.
Activities or mission (Part I)
PELOTONIA EXISTS TO ENGAGE, INSPIRE, AND CHALLENGE A COMMUNITY COMMITTED TO CHANGE THE WORLD BY ACCELERATING INNOVATIVE CANCER RESEARCH. SINCE ITS FOUNDING IN 2008, PELOTONIA HAS RAISED OVER $315 MILLION WHICH HAS BEEN INVESTED IN HIGH-IMPACT CANCER RESEARCH INCLUDING PREVENTION, DIAGNOSTICS, AND TREATMENT, AS WELL AS THE LAUNCH OF THE PELOTONIA INSTITUTE FOR IMMUNO-ONCOLOGY. AS A CENTERPIECE OF ITS YEAR-ROUND FUNDRAISING EFFORTS, PELOTONIA HOSTS A THREE-DAY EXPERIENCE THAT INCLUDES A WEEKEND OF CYCLING, ENTERTAINMENT, AND VOLUNTEERISM. THANKS TO ITS GENEROUS FUNDING PARTNERS, PELOTONIA IS ABLE TO DIRECT 100 PERCENT OF EVERY COMMUNITY-RAISED DOLLAR TO CANCER RESEARCH.
-
PELOTONIA SUPPORTS HIGH-RISK, HIGH-REWARD CANCER RESEARCH INITIATIVES AT THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER ARTHUR G. JAMES CANCER HOSPITAL AND SOLOVE RESEARCH INSTITUTE. THE FUNDS RAISED SUPPORT PROJECTS THAT ADDRESS MANY AREAS OF CANCER RESEARCH, INCLUDING PREVENTION, DIAGNOSIS, TREATMENT, PSYCHOSOCIAL ISSUES, ACCELERATED DRUG DEVELOPMENT, AND LARGE INITIATIVES THAT HELP CHANGE THE LANDSCAPE OF CANCER CARE AND OFFER HELP AND HOPE TO PATIENTS AND FAMILIES FROM AROUND THE WORLD. PELOTONIA FUNDS ARE NOT RESTRICTED TO SPECIFIC CANCER TYPES, ALLOWING US TO INVEST IN INNOVATION ACROSS ALL CANCERS, FUNDING THE HIGHEST PRIORITY AND QUALITY RESEARCH ANNUALLY. SEE SCHEDULE O.IN FY 2023, PELOTONIA AWARDED FELLOWSHIP PROGRAM AWARDS TO EMPOWER YOUNG INNOVATORS ACROSS ACADEMIC FIELDS AND DISCIPLINES TO PURSUE A CAREER IN CANCER RESEARCH; IDEA GRANTS TO ENABLE SCIENTISTS TO PURSUE NEW APPROACHES TO CANCER RESEARCH; AND STATEWIDE INITIATIVE GRANTS FOCUSED ON ASSESSING SURVIVAL AND QUALITY OF LIFE FOR ADVANCED STAGE LUNG CANCER, SMOKING CESSATION, AND REDUCING THE HIGH BREAST CANCER MORTALITY AMONG AFRICAN AMERICAN WOMEN IN OHIO. PELOTONIA CONTINUED ONGOING PROGRAMMATIC INVESTMENTS IN THE PELOTONIA INSTITUTE FOR IMMUNO-ONCOLOGY (PIIO); A COMPREHENSIVE BENCH-TO-BEDSIDE RESEARCH INITIATIVE FOCUSED ON HARNESSING THE IMMUNE SYSTEM TO FIGHT CANCER; RECRUITMENT AND RETENTION OF TOP CANCER SCIENTISTS; SOPHISTICATED EQUIPMENT REQUIRED FOR CUTTING-EDGE CANCER DISCOVERIES; STRATEGIC RESEARCH INVESTMENTS IN THE DRUG DEVELOPMENT INSTITUTE; DIGITAL PATHOLOGY; AND TOTAL CANCER CARE PROTOCOL PROGRAMS AT THE OSUCCC - JAMES.
Expenses $30,341,029 · Grants $28,298,537 · Revenue $12,095
-
IN 2022, PELOTONIA, IN COLLABORATION WITH VICTORIA'S SECRET AND THE AMERICAN ASSOCIATION OF CANCER RESEARCH, ESTABLISHED "THE VICTORIA'S SECRET GLOBAL FUND FOR WOMEN'S CANCERS," TO SUPPORT RESEARCH AIMED AT PREVENTING, DETECTING, TREATING AND SUPPORTING THE SURVIVORSHIP OF WOMEN WITH CANCER AND INVESTING IN THE NEXT GENERATION OF WOMEN SCIENTISTS WHO REPRESENT THE DIVERSE POPULATION THEY SERVE.
Expenses $2,631,380 · Grants $2,413,880
As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Abigail WexnerABIGAIL WEXNER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.25
-
Bobby SchottensteinBOBBY SCHOTTENSTEIN
CHAIR AND DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.25
-
Carol Bradford MD Ms FacsCAROL BRADFORD MD MS FACS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.25
-
Cindy HilsheimerCINDY HILSHEIMER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.25
-
Dan RosenthalDAN ROSENTHAL
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.25
-
Julie SloatJULIE SLOAT
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.25
-
Peter Mohler PhDPETER MOHLER PHD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.25
-
Raphael Pollock MD PhDRAPHAEL POLLOCK MD PHD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.25
-
Renee CacchilloRENEE CACCHILLO
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.25
-
Steve SteinourSTEVE STEINOUR
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.25
-
Victor CrawfordVICTOR CRAWFORD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.25
-
Doug UlmanDOUG ULMAN
VICE CHAIR
- Total calculated
- $391,470
- From this org
- $352,500
- From related orgs
- $0
- Other
- $38,970
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $277,500
- Bonus
- $75,000
- Other
- $0
- Deferred
- $10,260
- Nontaxable benefits
- $28,710
- Filer's total
- $391,470
-
Joseph ApgarJOSEPH APGAR
PRESIDENT AND CEO
- Total calculated
- $513,897
- From this org
- $471,674
- From related orgs
- $0
- Other
- $42,223
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $396,154
- Bonus
- $75,000
- Other
- $520
- Deferred
- $13,800
- Nontaxable benefits
- $28,423
- Filer's total
- $513,897
-
Nicholas DenbyNICHOLAS DENBY
CHIEF FINANCIAL OFFICER
- Total calculated
- $324,057
- From this org
- $284,537
- From related orgs
- $0
- Other
- $39,520
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $238,587
- Bonus
- $45,950
- Other
- $0
- Deferred
- $11,381
- Nontaxable benefits
- $28,139
- Filer's total
- $324,057
-
Katie WilsonKATIE WILSON
DIRECTOR OF MARKETING AND COMMUNICATIONS
- Total calculated
- $150,520
- From this org
- $150,520
- From related orgs
- $0
- Other
- $0
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $125,000
- Bonus
- $25,000
- Other
- $520
- Deferred
- $0
- Nontaxable benefits
- $0
- Filer's total
- $150,520
-
Eric OlsavskyERIC OLSAVSKY
VP OF COMMUNITY ENGAGEMENT AND PARTNERSHIPS
- Total calculated
- $274,448
- From this org
- $238,885
- From related orgs
- $0
- Other
- $35,563
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $198,365
- Bonus
- $40,000
- Other
- $520
- Deferred
- $7,706
- Nontaxable benefits
- $27,857
- Filer's total
- $274,448
-
Lauren GrahamLAUREN GRAHAM
DIRECTOR OF EVENT OPERATIONS
- Total calculated
- $156,951
- From this org
- $149,549
- From related orgs
- $0
- Other
- $7,402
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $124,029
- Bonus
- $25,000
- Other
- $520
- Deferred
- $5,982
- Nontaxable benefits
- $1,420
- Filer's total
- $156,951
-
Carolyn AppelhansCAROLYN APPELHANS
DIRECTOR OF COMMUNITY ENGAGEMENT
- Total calculated
- $131,213
- From this org
- $117,020
- From related orgs
- $0
- Other
- $14,193
- Hours/week
- 1
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Compensation committee
- 3 · Form 990 of other organizations
- 3 · Written employment contract
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
THE OHIO STATE UNIVERSITY JAMES CANCER HOSPITAL AND SOLOVE RESEARCH INSTITU
$25,217,200
CANCER RESEARCH
-
AMERICAN ASSOCIATION FOR CANCER RESEARCH
$2,404,530
CANCER RESEARCH
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 13 November 2025
- IRS schema version
- 2024v5.2
- Source object
- 202533189349305183
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.